Global Viral Vector Manufacturing Market Report 2023-2027 & 2032: Featuring Sanofi, Thermo Fisher Scientific, Merck Group, and Many Others


Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Viral Vector Manufacturing Market 2023" report has been added to ResearchAndMarkets.com's offering.

The global viral vector manufacturing market is expected to grow from $4.83 billion in 2022 to $5.82 billion in 2023 at a compound annual growth rate (CAGR) of 20.5%. The market is expected to reach $11.9 billion in 2027 at a CAGR of 19.8%.



The increase in the prevalence of cancer and infectious diseases is expected to propel the growth of the viral vector manufacturing market going forward. For instance, in May 2022, according to the World Health Organization, a Switzerland-based specialized health agency, compared to 245 million cases in 2020, there were 247 million cases of malaria in 2021. Furthermore, in June 2023, according to the Centers for Disease Control and Prevention, a US-based Department of Health and Human Services, there were 1,603,844 new cancer cases and 602,347 cancer-related deaths in the US in 2020. Therefore, the increase in the prevalence of cancer and infectious diseases is driving the growth of the viral vector manufacturing market.

Product innovation is a key trend gaining popularity in the viral vector manufacturing market. Major companies operating in the viral vector manufacturing market are introducing product innovations to sustain their position in the market. For instance, in August 2022, Merck KGaA, a German-based science and technology company, launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. One of the first Contract development and manufacturing organizations and technology creators to offer an entire viral vector manufacturing package, including AAV, Lentiviral, CDMO, CTO, and process development. With the help of this innovative platform, biopharmaceutical businesses may shorten the time and expense of process development while accelerating the time to clinical manufacture

North America was the largest region in the viral vector manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the viral vector manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Major players in the viral vector manufacturing market are:

  • AGC Biologics
  • Aldevron LLC
  • Batavia Biosciences BV
  • BioNTech IMFS GmbH
  • Catalent Inc.
  • Cevec Pharmaceuticals GmbH
  • Charles River Laboratories International Inc.
  • FinVector Oy
  • FUJIFILM Holdings Corporation
  • LakePharma Inc.
  • Lonza Group
  • Merck Group
  • Mustang Bio Inc.
  • Novasep Holding SAS
  • Oxford Biomedica plc
  • Regenxbio Inc.
  • Sanofi SA
  • Sartorius AG
  • Sirion-Biotech GmbH
  • Thermo Fisher Scientific Inc.
  • Ultragenyx Pharmaceutical Inc.
  • Univercells Technologies
  • VGXI Inc.
  • Vigene Biosciences Inc.
  • Voyager Therapeutics Inc.

In January 2021, Thermo Fisher Scientific Inc., a US-based supplier of software, services, analytical tools, reagents and consumables, and medical equipment, acquired Henogen S.A. for $874.5 million. With this acquisition, Thermo Fisher Scientific Inc. aims to increase its capacity for cell and gene therapies and vaccines worldwide. Henogen S.A. is a Belgium-based biomanufacturing company that manufactures viral vectors.

Key Attributes

Report AttributeDetails
No. of Pages175
Forecast Period2023-2027
Estimated Market Value (USD) in 2023$5.82 Billion
Forecasted Market Value (USD) by 2027$11.9 Billion
Compound Annual Growth Rate19.6%
Regions CoveredGlobal

Key Topics Covered

1. Executive Summary

2. Viral Vector Manufacturing Market Characteristics

3. Viral Vector Manufacturing Market Trends and Strategies

4. Viral Vector Manufacturing Market - Macro Economic Scenario
4.1. Impact of High Inflation on Online Therapy Services Market
4.2. Ukraine-Russia War Impact on Online Therapy Services Market
4.3. COVID-19 Impact on Online Therapy Services Market
5.1. Global Viral Vector Manufacturing Historic Market Size and Growth, 2017-2022, Value ($ Billion)
5.2. Global Viral Vector Manufacturing Forecast Market Size and Growth, 2022-2027, 2032F, Value ($ Billion)
5.3. Global Viral Vector Manufacturing Market Drivers and Restraints
5.3.1. Drivers of the Market
5.3.2. Restraints of the Market

6. Viral Vector Manufacturing Market Segmentation
6.1. Global Viral Vector Manufacturing Market, Segmentation by Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
  • Lentiviral Vectors
  • Retroviral Vectors
  • Other Types

6.2. Global Viral Vector Manufacturing Market, Segmentation by Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Other Diseases

6.3. Global Viral Vector Manufacturing Market, Segmentation by Workflow, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Upstream Processing
  • Downstream Processing

6.4. Global Viral Vector Manufacturing Market, Segmentation by Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Gene and Cell Therapy Development
  • Vaccine Development
  • Biopharmaceutical and Pharmaceutical Discovery
  • Biomedical Research

6.5. Global Viral Vector Manufacturing Market, Segmentation by End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Research Organizations
  • Biotech and Pharmaceutical Companies
  • Others End Users

7. Viral Vector Manufacturing Market Regional and Country Analysis
7.1. Global Viral Vector Manufacturing Market, Split by Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Viral Vector Manufacturing Market, Split by Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/qb9y9a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Viral Vector Manufacturing Market

Kontaktdaten